BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-667@pharmaconomics
DTSTAMP:20260707T050321Z
DTSTART;VALUE=DATE:20260630
DTEND;VALUE=DATE:20260701
SUMMARY:PGEN Phase 1 — PAPZIMEOS (estimated date)
DESCRIPTION:Phase 1 trial results for PAPZIMEOS in Recurrent Respiratory Papillomatosis (RRP) are due ~ Jun 30\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1356090/000095010326007158/dp246650_ex9901.htm\n\nTrack it: https://www.pharmaconomics.com/e/667
URL:https://www.pharmaconomics.com/e/667
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:PGEN catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR